• Corpus ID: 89039451

A Weird Concept with Unusual Fate: Nootropic Drug

  title={A Weird Concept with Unusual Fate: Nootropic Drug},
  author={Doru Georg Margineanu},

Figures from this paper

The interplay of authority and expertise in online self-improvement communities

............................................................................................................. 6 Lay Summary

[Circulation of information on drugs and other substances to increase cognitive performance: a study of a Brazilian blog (2015-2017)].

The results show that the blog acts as a medium for spreading biomedical knowledge among the lay public and indicates the production of new forms of subjectivity by revealing the meanings attributed to these substances in socialization processes.

Augmented memory: a survey of the approaches to remembering more

  • C. Madan
  • Philosophy
    Front. Syst. Neurosci.
  • 2014
This work discusses four general approaches that have been developed to augment human long-term memory: nootropics agents, brain stimulation, mnemonic strategies, and external aids, and presents a summary of each approach.

Aprimoramento cognitivo e a produção de modos de subjetividade: um estudo sobre o uso de substâncias “nootrópicas” a partir de um blog brasileiro

Resumo O consumo de medicamentos para aprimorar processos mentais, como memória, concentração e estado de alerta, tem se expandido. As chamadas smart drugs e fármacos nootrópicos são utilizados na

Nootropics: Phytochemicals with Neuroprotective and Neurocognitive Enhancing Properties

Nootropics open the door for new research, clinical implementation and promotion of integrative health especially in cognitive neuroscience by implementing products of natural sources to improve neurocognitive functioning and health improvement.

Ethical Underpinning and Implications of “Nootropic” Concept

  • P. Rudra
  • Psychology
    Acta Universitatis Lodziensis. Folia Philosophica. Ethica-Aesthetica-Practica
  • 2018
The current generation paving the path for new research marks a milestone to attain the ancient goal of improving our cognition. To date, increased prevalence of cognitive enhancers by healthy people

The Speculative Neuroscience of the Future Human Brain

The hallmark of their species is their ability to hybridize symbolic thinking with behavioral output, where for the first time the authors are in a position to willfully alter the brain and hence, their behavior and evolution.



Piracetam: a review of pharmacological properties and clinical uses.

  • B. Winblad
  • Medicine, Psychology
    CNS drug reviews
  • 2005
Piracetam, a derivative of the neurotransmitter gamma-aminobutyric acid (GABA), has a variety of physiological effects that may result from the restoration of cell membrane fluidity, and its efficacy is documented in cognitive disorders and dementia, vertigo, cortical myoclonus, dyslexia, and sickle cell anemia.

Piracetam and Piracetam-Like Drugs From Basic Science to Novel Clinical Applications to CNS Disorders

A major focus of the literature search was on articles demonstrating evidencebased clinical investigations during the past 10 years for the following therapeutic categories of CNS disorders: (i) cognition/memory; (ii) epilepsy and seizure; (iii) neurodegenerative diseases; (iv) stroke/ischaemia; and (v) stress and anxiety.

THE WEB OF LIFE : A New Synthesis of Mind and Matter

The vitality and accessibility of Fritjof Capra's ideas have made him perhaps the most eloquent spokesperson of the latest findings emerging at the frontiers of scientific, social, and philosophical

Piracetam in Patients with Chronic Vertigo

Findings provide further evidence that piracetam alleviates vertigo by reducing the frequency of episodes, the severity of malaise and imbalance between episodes, and the duration of associated incapacity.

Piracetam defines a new binding site for allosteric modulators of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptors.

The structure of the ligand binding domain of the AMPA receptor subtypes GluA2 and GLUA3 with piracetam and a corresponding structure of Glu a3 with aniracetam is determined.

Molecular targets underlying general anaesthesia

  • N. Franks
  • Biology
    British journal of pharmacology
  • 2006
The work that led up to the identification of the GABAA receptor as the key target for etomidate and propofol is described and current progress that has been made in identifying the relevant targets for other anaesthetics, particularly the inhalational agents is compared.

Adjunctive brivaracetam for refractory partial-onset seizures

This interventional study provides preliminary Class I evidence that adjunctive BRV was efficacious and well-tolerated in patients aged 16–65 years with POS.